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Abstract 12 
Assessing blood concentration of persistent organic pollutants (POPs) in infants is difficult due to the ethical 13 
and practical difficulties in obtaining sufficient quantities of blood. To determine whether measuring POPs in 14 
faeces might reflect blood concentration during infancy, we measured the concentrations of a range of POPs (i.e. 15 
polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs) and organochlorine pesticides 16 
(OCPs)) in a pilot study using matched breast milk and infant faecal samples obtained from ten mother-child 17 
pairs. All infants were breast fed, with 8 of them also receiving solid food at the time of faecal sampling. In this 18 
small dataset faecal concentrations (range 0.01 - 41ng/g lipid) are strongly associated with milk concentrations 19 
(range 0.02 - 230 ng/g lipid). Associations with other factors generally could not be detected in this dataset, with 20 
the exception of a small effect of age or growth. Different sources (external or internal) of exposure appeared to 21 
directly influence faecal concentrations of different chemicals based on different inter-individual variability in 22 
the faeces-to-milk concentration ratio Rfm. Overall, the matrix of faeces as an external measure of internal 23 
exposure in infants looks promising for some chemicals and is worth assessing further in larger datasets.  24 
 25 
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1. Introduction  28 
 29 
The link between exposure to some persistent organic pollutants (POPs)  and endocrine disrupting/ carcinogenic 30 
effects seems to be clear from laboratory studies on a range of biota (Tanabe, 2002; Li et al., 2006; Alonso-31 
Magdalena et al., 2011; Bergman et al., 2013), and there is increasing evidence that exposure in early life is an 32 
important determinant of long-term disease risk (Nagayama et al., 2007; Ochiai et al., 2014). However, more 33 
large-scale epidemiological studies are needed for understanding the exposure window that can elicit effects and 34 
the extent of the contribution of lipophilic pollutants to the increased risk of incommunicable diseases in 35 
humans (Nickerson, 2006; Jorissen, 2007). Infancy is a critical stage of development and is associated with 36 
unique exposure pathways that can increase exposure to lipophilic pollutants (Solomon and Weiss, 2002). 37 
Nevertheless, exposure assessment in early life is challenging and complicated by reluctance of parents and 38 
investigators to take blood samples from infants. In addition, the small volume sample that may be obtained 39 
poses technical challenges for measuring analytes.  40 
 41 
To avoid sampling blood, physiologically based pharmacokinetic (PBPK) models have been used to generate 42 
individualized toxicokinetic profiles of lipophilic pollutants in infants. Such models usually contain many 43 
variables, such as: the initial value (e.g., the concentration in meconium or umbilical cord blood), ongoing 44 
exposure values (e.g., concentrations in mother’s breast milk), intrinsic elimination values (estimated from 45 
assembled data from longitudinal monitoring data or estimated via measuring excretion rate) and infants’ 46 
growth rate (Lorber and Phillips, 2002; Verner et al., 2013). Each of these variables is uncertain, and 47 
consequently the modelled exposure of the infant can also be associated with considerable uncertainty. In this 48 
context, finding a non-invasive matrix that has a direct relationship with the blood concentration and can be 49 
measured repeatedly throughout infancy would improve exposure assessment of lipophilic pollutants in infants. 50 
 51 
Evidence in adults suggests that the faecal concentration of some lipophilic pollutants (polychlorinated dibenzo-52 
p-dioxins and dibenzofurans (PCDD/Fs), polychlorinated biphenyls (PCBs) and hexachlorobenzene (HCB)) is 53 
directly related to the blood concentration. Schrey et al. (1998) reported that faecal excretion of most PCDD/Fs 54 
examined exceeded the daily intakes from food (Schrey et al., 1998). Moser and McLachlan also found that 55 
altering dietary exposure did not influence faecal excretion of PCDD/Fs, HCB, and PCBs (Moser and 56 
McLachlan, 2001), which means faecal concentration was not affected by the concentration of POPs in diet. 57 
Further, Rohde et al. found a correlation between levels in blood and levels in faeces for PCDD/Fs over a very 58 
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broad concentration range (Rohde et al., 1999). To-Figueras and his team pointed out a strong correlation 59 
between HCB levels in faeces and in serum (To-Figueras et al., 2000).  60 
 61 
In two breast fed children, faecal excretion of PCDD/Fs was found not to decrease during the weaning period to 62 
the same extent as the estimated decrease in exposure/uptake resulting from substituting breast milk with a solid 63 
diet (Abraham et al., 1996), implying that the faecal concentration in these two infants was at least partially 64 
determined by the blood concentration.  65 
 66 
Maternal breast milk is considered the most accessible matrix that provides reliable information related to the 67 
intake of lipophilic pollutants in the corresponding infant (Verner et al., 2013) for those chemicals for which 68 
uptake via food is the primary exposure pathway for the infant (although dust is acknowledged as another 69 
important source for some POPs) (Toms et al., 2009; Lee et al., 2014). In addition, after a decline during the 70 
first month of lactation, concentrations of lipophilic pollutants in breast milk have been found to remain steady 71 
throughout the breastfeeding period, and to be close to the initial infant blood concentrations (Abraham et al., 72 
1994; Lee et al., 2013; Verner et al., 2013; Vigh et al., 2013).  73 
 74 
The key aims of this study were: to assess the concentration of a range of POPs (PCBs, polybrominated 75 
diphenyl ethers (PBDEs) and organochlorine pesticides (OCPs)) in matched infant faeces and breast milk 76 
samples with reproducible results; to evaluate whether concentrations in the two media are correlated; and to 77 
evaluate whether faecal concentrations can potentially be used as biomarkers of the blood concentration of POPs 78 
in infants.  79 
 80 
2. Materials and methods  81 
 82 
2.1 Chemicals 83 
 84 
Standard solutions of native PCBs, PBDEs and OCPs were purchased from AccuStandard Inc.. Isotopic carbon-85 
labelled PCB standard solutions and PBDE standard solutions were purchased from Wellington Laboratories 86 
Inc., and isotopic carbon-labelled OCP standards were ordered from Cambridge Isotope Laboratories Inc.. n-87 
Hexane (SupraSolv®), dichloromethane (DCM, SupraSolv®), granulated anhydrous sodium sulphate (Scharlau 88 
Chemie S.A.), silica (Davisil Grade 633, Sigma-Aldrich®) and Florisil® (Fluka, Sigma-Aldrich®) were used for 89 
extraction and clean-up. Silica and Florisil were activated at 140 °C for at least 12 hours before use. Sodium 90 
sulphate was baked at 400 °C for at least 12 hours before use. 91 
 92 
2.2 Recruitment and sample collection 93 
 94 
This project received ethics approval by The University of Queensland Ethics Committee (approval number 95 
H/308 NRCET). Ten mothers were recruited opportunistically when they were pregnant, from Sydney (7) and 96 
Brisbane (3), Australia. Breast milk samples were collected in August, 2013. A minimum of 50 ml of breast 97 
milk was collected from each mother over multiple collections over a one-month period into a clean glass jar 98 
that was provided. These mothers then collected faecal samples from their infants twice a week for two weeks, 99 
beginning 12-20 weeks after breast milk sampling. Only faecal material that had not been in contact with the 100 
inner liner of the diaper was collected (Supporting Information Instruction for Sampling Faeces). 101 
Questionnaires requesting demographic information about each mother /infant pair were completed by the 102 
mothers (Supporting Information Tables S1, S2). Breast milk and faecal samples were stored in a freezer at the 103 
participants’ homes until transportation (on ice, in a cool bag) to the laboratory. In the laboratory, samples were 104 
stored at -20 °C until analysis. 105 
 106 
2.3 Sample analysis 107 
 108 
Lipid content in milk samples was determined gravimetrically in an aliquot based on a liquid-liquid extraction 109 
protocol. Approximately 1 g of homogenized milk sample was weighed in a 15 ml centrifuge tube. Then 2 ml of 110 
methanol, 1 ml of methyl tert-butyl ether (MTBE) and 1 ml of hexane were added consecutively. The centrifuge 111 
tube was shaken vigorously (10 min), sonicated (10 min) and centrifuged at 2000 rpm (10 min). The upper layer 112 
was transferred to a pre-weighed tube. Again 1 ml TBME and 1 ml hexane were added to the original tube 113 
which then was shaken (10 min), sonicated (20 min) and centrifuged at 4000 rpm (10 min). The upper layers 114 
were combined and blown down to dryness. The tube was put into a 103 °C oven and weighed periodically until 115 
a stable reading was obtained.  116 
 117 
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For contaminant analysis, the homogenized milk sample (~6 g) was transferred to a centrifuge tube and spiked 118 
with labeled standard solution (see Table S3 in the Supporting Information). The milk was extracted as 119 
described above for lipid content measurement. After concentrating the extract to about 1 ml, it was applied onto 120 
the top of a glass column (30 cm × 1.0 cm i.d.) containing 1 cm of anhydrous NaSO4, 14 cm of alumina, 14 cm 121 
of florisil and 1 cm of NaSO4 from top to bottom. The sample was then eluted with 100 ml of a mixture of 122 
hexane and DCM (1:1 V:V). The eluate was concentrated to 0.5 ml and applied onto the top of another column 123 
(17 cm × 0.8 cm i.d.) containing 0.5 cm of NaSO4 and 15 cm of silica gel from top to bottom. The second 124 
column was then eluted with 30 ml of a mixture of hexane and DCM (1:1 V:V). The eluate was concentrated to 125 
25 µl and 25 µl isooctane containing 200 pg 13C-PCB141 was added as the recovery standard right before 126 
instrumental analysis.   127 
 128 
The homogenized, freeze-dried faecal samples (~3 g) from each infant were placed into 100 ml ASE cells with 129 
10 g silica gel, spiked with internal standards and then extracted using hexane and DCM (1:1 V:V) on a Thermo 130 
Scientific™ Dionex™ ASE™ 350 Accelerated Solvent Extractor system. The program was: 100 °C, 1500 psi, 3 131 
static cycles of 7 minutes and purge time of 120 seconds. The extracts were transferred to a column (1.2 cm i.d.) 132 
containing 20 cm silica, and eluted with 100 ml of a hexane/DCM mixture (1:1 V:V). The extract was 133 
concentrated and transferred to another column (1.2 cm i.d.) containing 20 cm florisil, and eluted with 80 ml 134 
hexane/DCM (1:1 V:V). The hexane and DCM (1:1 V:V) extractable lipid content of the samples was 135 
determined in a separate extraction employing ASE with the same conditions as above, followed by evaporation 136 
to dryness and gravimetric determination of the lipid content. 137 
 138 
2.4 Instrumentation, Analysis and Quantification 139 
 140 
All samples were analysed for indicator PCBs (PCB 28, 52, 101, 118, 138, 153 and 180), PBDEs (PBDE 47, 99, 141 
100, 153 and 154) and OCPs (pentachlorobenzene (PeCB), hexachlorobenzene (HCB), heptachlor, heptachlor 142 
epoxide B, heptachlor epoxide A, mirex and p,p’-DDE) using a Thermo Fisher GC 1310-HRMS DFS operated 143 
in EI-MID mode. A DB-5MS column (30 m × 0.25 mm × 0.25 μm, J&W Scientific) was used. All the samples 144 
were analysed at a resolution ≥5000. The internal standard quantification method was used. The signal/ noise 145 
(S/N) ratio was above 10 for all quantified peaks. 146 
 147 
2.5 Quality control 148 
 149 
For every 5 samples analysed, a blank sample was included to check laboratory contamination. Cow’s milk was 150 
used as the blank for breast milk, while diatomaceous earth was used as the blank for faeces. The method limit 151 
of quantification (mLOQ) of one compound was defined as the mean value of its concentration in blank samples 152 
plus 10 times its standard deviation, while the limit of detection was set at the mean plus 3 times the standard 153 
deviation. The data were blank-corrected by subtracting the mean concentrations of target compounds observed 154 
in the blanks. Diaper liners were also analysed as quality control samples, and low concentrations of target 155 
compounds were observed (Supporting Information Table S4). To minimize contamination, liners with the 156 
faecal samples were taken out of the diaper right after the infants’ bowel movement and the faecal samples were 157 
then tipped into a pre-cleaned aluminium foil sheet (faecal material that had been in contact with the inner liner 158 
of the diaper was carefully retained), folded up, and put into the freezer immediately.  159 
 160 
The average recoveries of the 13C-labelled standards ranged from 30-110% (in breast milk samples) and 32-161 
112% (in faeces samples) (Supporting Information Table S3). Replication of lipid analysis showed good 162 
reproducibility with a coefficient of variation (CV) of 4.5% for breast milk and 6.9% for faeces. Two replicates 163 
(i.e. subsamples of a common sample) were analyzed for three of the breast milk and all 10 faeces samples. 164 
Average coefficients of variation (CV) of the concentrations were 13% and 19% for breast milk and faeces, 165 
respectively; larger differences (20% - 40%) were observed for chemicals that were measured at relatively low 166 
concentrations (Supporting Information Table S5, S6). Where replicates were analyzed the mean concentration 167 
of the two replicates was used for further statistical analysis of association.  168 
 169 
2.6 Statistical analysis 170 
 171 
Multiple linear regression analyses examining potential associations between log10-transformed faecal 172 
concentrations and factors including log10-transformed milk concentration (data log10-transformed for normal 173 
distributions), other feeding characteristics, and age were performed using STATA IC 12 (College Station, TX, 174 
USA). For regression analyses, measures below limit of detection (LOD) were imputed as LOD/2; measures 175 
between LOD and the mLOQ were imputed using the average of two determinations.   176 
 177 
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 178 
3. Results and discussion  179 
 180 
3.1 Concentration of POPs in breast milk and infant faeces 181 
 182 
A range of PCB congeners, BDE congeners and OCPs were detected in both faeces and breast milk samples 183 
(Table 1; detailed information for individual samples is presented in the Supporting Information Table S5, S6). 184 
PCB 52, 101, PBDE 154, heptachlor and heptachlor epoxide A were detected above the mLOQ in less than half 185 
of the breast milk samples, and PBDE 154 and heptachlor epoxide A were detected above the mLOQ in less 186 
than half of the faeces samples, as indicated by the shaded rows in Table 1. For this reason, these 5 compounds 187 
are not discussed further. This is the first time that concentrations of these three groups of POPs in faeces have 188 
been reported in one study.  189 
 190 
The highest concentration in breast milk was measured for PCB 153 (1.3 - 24 ng/g lipid) among PCBs, BDE 47 191 
(0.27 - 8.5 ng/g lipid) among PBDEs and p,p’-DDE (9.0 - 230 ng/g lipid) among OCPs. Concentrations of 192 
individual chemicals varied typically between 1 and 2 orders of magnitude among all mothers (Table S5). This 193 
range is much greater than the uncertainty in the measurement of the concentrations (as indicated by the 194 
replicate analyses, see above), indicating that the dataset provides a good basis for assessing possible 195 
relationships between concentrations in breast milk and concentrations in faeces. One potential reason for this 196 
relatively large variation in concentrations in breast milk is that the study included mothers with a range of 197 
different ethnicities/origins including mothers who had lived abroad for most of their lives. Chemical specific 198 
differences in exposure between different countries/continents have been demonstrated in many studies 199 
(Solomon and Weiss, 2002). Other reasons may include differences in age and diet (Supporting Information 200 
Table S1).  201 
 202 
This variation was reflected in the concentrations in faeces (Table S6), which ranged from 0.44 - 12 ng/g lipid 203 
for PCB 153, 0.34 - 15 ng/g lipid for BDE 47, and 4.0 - 41 ng/g lipid for p,p’-DDE. For PCB 153 the lowest 204 
concentrations in both breast milk and faeces were observed in Pair 4, while the highest concentrations in both 205 
matrices were observed in Pair 6. For BDE 47, the lowest concentrations in both matrices were from Pair 7 and 206 
the highest concentrations in both matrices were from Pairs 10 and 6. The highest levels of DDE occurred in 207 
Pairs 6 and 9 for both matrices. The relationship between concentration of POPs in breast milk and in infant 208 
faeces is explored in more detail below.  209 
 210 
3.2 Relationship between the log-transformed faecal concentration of POPs and a variety of factors 211 
 212 
In this study, we examined the relationship between the log-transformed faecal concentration of all 14 213 
compounds from Table 1 and a variety of factors including: log- transformed milk concentrations; infant age in 214 
months; adjusted months of breastfeeding; fraction of total feeding due to breastfeeding (adjusted breastfeeding 215 
months/age); adjusted months of solid food; total weight gain; and rate of weight gain (Table S2, S7). A variety 216 
of possible interrelationships among these variables were also examined in order to identify potential co-217 
variation that could affect the regressions. 218 
  219 
Measured faecal concentrations for all analytes together are correlated with milk concentrations (Fig. 1; 14 220 
analytes, 10 paired measurements for each; Pearson corr. Coeff. =0.72).  221 
 222 
Adding other factors related to milk concentration in general did not result in significant independent 223 
contribution to the observed relationship. There was no significant relationship with months of breastfeeding, 224 
fraction of life breastfed, or conversely, months of solid food intake.  However, because of the small number of 225 
pairs, no definite conclusions can be drawn regarding these factors based on this dataset. 226 
 227 
Age was an independent, inverse predictor of faecal concentration (p=0.017) when added into the model with 228 
milk concentrations, but the relationship was very slight, and adding age resulted in only a small improvement 229 
in the adjusted R-squared (0.54 vs. 0.52 for milk concentration alone) (Table 2). 230 
 231 
Similarly, absolute change in weight (but not rate of weight change) was also borderline significant when added 232 
to milk concentrations in the model (p= 0.092), with the findings again in the inverse direction – greater weight 233 
gain results in slightly lower faecal concentrations (R2 of 0.53). However, those two parameters, age and change 234 
in weight, are highly correlated (Pearson corr. coeff. = 0.95), so it is not possible to determine which of the two 235 
contributed more to faecal concentrations.  In summary, in this small dataset faecal concentrations are highly 236 
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predicted by milk concentrations, and other factors cannot be detected in this dataset, with the exception of a 237 
small effect of age or growth.  238 
 239 
Two possible mechanisms are postulated for a monotonic correlation between human milk and infant faeces. 240 
The first mechanism is that some portion of the ingested chemical is excreted in the faeces without having been 241 
absorbed systemically, and that the concentration in the milk is a good surrogate for the infant’s ingestion of the 242 
chemical. The second mechanism is that the chemical concentration in the faeces is controlled by the chemical 243 
concentration in the body, and that the concentration in the milk is a good surrogate for the concentration in the 244 
body of the infant during the time of breastfeeding. A mixture of these two mechanisms may also operate 245 
depending upon the specific chemical and the exposure matrix (food, dust, or other matrix).  Further elucidation 246 
of these two mechanisms will likely require additional datasets, in particular, datasets with blood concentration 247 
data and including infants or small children that are not being currently breastfed as well as those that are. 248 
 249 
3.3 Chemical-specific observations  250 
 251 
This dataset can neither confirm nor refute the hypothesis that faecal concentration reflects blood concentration. 252 
However, we can use the ratio of concentrations of POPs in faeces samples (Cf, in ng/g lipid) to that in milk 253 
samples (Cm, in ng/g lipid): 254 
  255 
Rfm = Cf / Cm  256 
 257 
to explore which of the two explanations for the monotonic correlation between Cf and Cm might apply to the 258 
different compounds. The Rfm values for each compound in each pair of samples (only the pairs that have data 259 
above mLOQ) are presented in the Supporting Information Table S8.  A compound specific summary of the 260 
data is presented in Table 1. The Rfm for individual samples ranged from 0.044 for DDE and PCB 180 to 4.2 for 261 
PCB 28, and the median Rfm ranged from 0.20 for PCB 153 and HCB to 1.1 for BDE 47.   262 
 263 
For a given chemical, Rfm varied among mother/infant pairs by as little as a factor < 2.5 for BDE 47 up to a 264 
factor >32 for Heptachlor epoxide B (Fig. 2, Table S8,  Fig. S1). The different variability in Rfm between 265 
chemicals indicated that different factors were involved for different chemicals in determining the relationship 266 
between Cf and Cm. If the hypothesis that faecal concentration reflects concentration in the infant’s body (i.e., 267 
the second mechanism outlined above) is true, one would expect high variability of Rfm. This is because 268 
pharmacokinetic modeling has shown that the relationship between Cm and concentrations in the infant’s body is 269 
strongly influenced by e.g., age and length of breastfeeding (Verner et al., 2013). On the other hand, if the faecal 270 
concentration reflects the amount of chemical ingested (the first mechanism outlined above), one would expect 271 
low variability of Rfm under certain conditions. This would be the case if the mother’s milk was the dominant 272 
source of ingested chemical and the chemical’s absorption efficiency did not vary widely between individuals. It 273 
would also be the case if another source besides mother’s milk dominated the infant’s ingestion, and if the same 274 
source also dominated the mother’s exposure. 275 
 276 
The variability of Rfm between pairs for the major BDEs, i.e. BDE47 and BDE153 is comparatively very small 277 
(Table 1, Fig 2). This would speak for the faecal concentrations reflecting the amount of these chemicals 278 
ingested. Dust is considered one of the primary vectors of the exposure of the mother and the infant for BDEs 279 
(Trudel et al., 2011) and it is reasonable to assume that the levels of these chemicals in mother’s milk and in 280 
food/dust are correlated for mothers that are living in the same (dust) environment. The relatively large molar 281 
mass of BDEs could also resort in restricted absorption in the digestive tract (Kelly et al., 2004), which would 282 
favor this mechanism. 283 
  284 
For remaining compounds, it is noteworthy the lowest Rfm values for PCB118, 138, 153,180, DDE and mirex all 285 
occur with Pair 1. Besides Pair 1, other two pairs, i.e. Pair 9 and Pair 2, have the biggest numbers of compounds 286 
(5 and 3, respectively) with the lowest Rfm values among all pairs. Those mother/infant pairs with the lowest Rfm 287 
values are pairs that have older children and the longest periods of solid food being introduced before faecal 288 
samples were collected (see Table S8). The combination of these factors would be expected to lower Rfm. In 289 
addition, PCBs and HCB have been proved to have very high absorption efficiency in gut both adults and 290 
infants (McLachlan, 1993; Abraham et al., 1994; Moser and McLachlan, 2002). This would speak more for the 291 
faecal concentrations reflecting the concentrations in the infant’s body.  292 
 293 
The primary purpose of this pilot study was to demonstrate that a large range of compounds could be measured 294 
in feces with reproducible results. The strong correlations between maternal milk and faecal concentrations, 295 
whether due to faeces levels directly reflecting milk levels, indirectly reflecting another common exposure 296 
pathway for mother and infant, or reflecting levels in the infant’s body, suggest that faeces is a promising matrix 297 
6 
 
for biomonitoring infant exposure to POPs. Additional data, including blood concentration data paired to faecal 298 
data, are being generated to further evaluate the use of faecal concentrations as a marker for internal exposure of 299 
infants and children.  In future work it is important that a broad spectrum of chemicals be studied as the faeces 300 
concentrations of different chemicals are clearly influenced by different factors. Longitudinal studies will also 301 
be important to see how the concentrations in faeces change over time in the same infant as a result of changes 302 
in concentrations in blood and changes in exposure vectors such as diet and dust ingestion.  303 
 304 
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